New England Scores Another Touchdown as 1Q17 Pharma-Bio Project Starts Top $500 Million
New England Scores Another Touchdown as 1Q17 Pharma-Bio Project Starts Top $500 Million
SUGAR LAND--February 13, 2017--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--The playing fields within NFL stadiums are not the only place New England emerges a victor. The region has long been favored by the Pharmaceutical-Biotech Industry, home to a stunning roster of major companies, along with nascent but promising start-ups.
Within this article: Siemens AG's $300 million planned expansion of its diagnostic test kit and gas sensor manufacturing facility in East Walpole, Massachusetts.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Siemens' 10 Top-Valued U.S. Projects Point to Growth of Shale Gas Demand
- New England Sees More than $10 Billion on the Horizon for Project Kickoffs ...
- Rhode Island Hosts $315.25 Million in Project Kickoffs for 2016
- New England Claims $2 Billion Slice of 2016 Pharmaceutical-Biotech Capital/...
- Big-Ticket Items Lead North Carolina to $18.7 Billion in Projects Under Con...